Meta-analysis: VR exposure therapy works as well as in-person exposure for anxiety
How this was rated
Quantitative meta-analysis with sound methodology, but pooled across a limited number of primary studies (most with small samples). Useful as historical context and direction-of-evidence; later meta-analyzes (Opriş 2012) extend the picture.
Ratings use a simplified four-tier scheme (High, Moderate, Low, Very Low) informed by the GRADE working group. Learn more about how studies are rated.
An early quantitative meta-analysis pooled effect sizes across studies of VR exposure therapy for anxiety disorders, finding VR exposure equally effective as in-vivo (real-world) exposure and significantly more effective than control conditions.
An early meta-analysis providing pooled evidence that VR exposure produces effects comparable to in-vivo exposure for anxiety disorders; the analysis is bounded by the small number of high-quality primary trials available at the time.
Key findings
- VR exposure vs control conditions: large pooled effect (Cohen's d = 1.11, 95% CI 0.82-1.39); 13 studies pooled, total n=397
- VR exposure vs in-vivo exposure: VR showed a small effect size FAVOURING VR over in-vivo (Cohen's d = 0.35, 95% CI: 0.05-0.65) - not just comparable, slightly better
- Effects consistent across 5 secondary outcome categories: domain-specific anxiety, general subjective distress, cognition, behavior, psychophysiology
- Dose-response trend: p=0.06 (close to but not quite significant)
- Authors cautioned against generalization due to modest number of primary VR exposure trials at the time
Background
By 2008, virtual reality exposure therapy had accumulated enough primary studies that a quantitative synthesis was feasible. Individual trials had reported encouraging results, but the question that practitioners actually wanted answered required pooling across studies: how does VR exposure compare to in-vivo exposure (the established gold-standard delivery mode), and how does it compare to no treatment? Powers and Emmelkamp set out to answer those questions through formal meta-analysis.
What the researchers did
The authors conducted a systematic review and quantitative meta-analysis of randomized controlled trials of VR exposure therapy for anxiety disorders. Inclusion criteria required random assignment, standardized anxiety outcome measures, and a clearly defined VR-based exposure intervention. Effect sizes were calculated for VR exposure versus control conditions and for VR exposure versus in-vivo exposure where head-to-head comparisons were available.
What they found
Pooled effect sizes for VR exposure versus control conditions were large and statistically significant (Cohen’s d = 1.11, 95% CI 0.82-1.39; 13 studies, total n=397). Effects were consistent across five secondary outcome categories: domain-specific anxiety, general subjective distress, cognition, behavior, and psychophysiology.
Comparisons against in-vivo exposure produced a counterintuitive finding: VR showed a small but statistically significant advantage over in-vivo exposure (Cohen’s d = 0.35, 95% CI: 0.05-0.65) - not merely comparable, but slightly better. A dose-response trend was identified (p=0.06) but did not reach conventional statistical significance. The authors explicitly cautioned that the number of high-quality stand-alone VR-exposure trials was modest, particularly for social anxiety and other complex anxiety conditions, and that pooled estimates should be interpreted accordingly.
Why this matters
This was one of the first formal demonstrations that the body of evidence on VR exposure, taken together, supported the modality as comparable to in-vivo exposure. The conclusion was modest and properly hedged - not a triumphant declaration but a methodologically careful “the evidence to date supports comparability.” Subsequent meta-analyzes (notably Opriş et al. 2012) have extended the analysis with more primary studies and more granular subgroup findings. For speech-language professionals, the broader implication is that VR exposure for anxiety disorders has a meta-analytic foundation, which contextualizes the use of similar VR-exposure principles for the speaking-anxiety component of communication work.
Limitations
The number of primary RCTs available in 2008 was modest, particularly for social anxiety and other conditions most relevant to communication work. Several included trials had small samples or methodological constraints. As the authors noted, generalization beyond the specific conditions and contexts represented in the primary studies should be cautious. The meta-analysis predates several methodologically stronger trials, including Anderson et al. 2013 and Bouchard et al. 2017.
Implications for practice
Clinicians can offer VR exposure as an evidence-based alternative to in-vivo exposure for anxiety conditions. The historical caution about a thin primary-study base has been partially addressed by subsequent trials, but treatment selection should consider available evidence for the specific condition being addressed.
Implications for research
The meta-analysis identified a need for larger primary trials with active comparators - a need partially addressed by subsequent work but still ongoing. Direct extension to communication-specific populations (people who stutter, voice clients) remains a research opportunity.
Where this connects to Therapy withVR
The study above is independent research and does not endorse any product. The notes below are commentary from withVR on how the themes in this research relate to features of Therapy withVR. The research findings are not claims about Therapy withVR.
Graded Exposure Hierarchy
This early meta-analysis confirmed VR exposure equals in-vivo exposure - Therapy withVR's hierarchical environment design supports the same exposure principles.
Cite this study
If you reference this study in your work, the canonical citation formats are:
@article{powers2008,
author = {Powers, M. B. and Emmelkamp, P. M. G.},
title = {Virtual reality exposure therapy for anxiety disorders: a meta-analysis},
journal = {Journal of Anxiety Disorders},
year = {2008},
doi = {10.1016/j.janxdis.2007.04.006},
url = {https://withvr.app/evidence/studies/powers-emmelkamp-2008}
}TY - JOUR
AU - Powers, M. B.
AU - Emmelkamp, P. M. G.
TI - Virtual reality exposure therapy for anxiety disorders: a meta-analysis
JO - Journal of Anxiety Disorders
PY - 2008
DO - 10.1016/j.janxdis.2007.04.006
UR - https://withvr.app/evidence/studies/powers-emmelkamp-2008
ER - Know of research that should be in this hub? If a relevant peer-reviewed study is not listed here, send the reference to hello@withvr.app. The hub is kept up to date as the literature grows.
Funding & independence
No withVR BV involvement in funding, study design, or authorship. Summary prepared independently by withVR using the published paper.